CVM

CEL SCI CORP CVM

NYSESmall CapHealthcare

13F Pro Quality Score

Not in ranked universe

Below size threshold

Below the main board's size threshold of $25M annual revenue or $100M total assets. This company reported $1.0M in revenue and is scored on the micro-cap board instead.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

Net income

$-5.67M

Quarter to Jun 30

Free cash flow

$-4.03M

Quarter to Jun 30

Top Institutional Holders

as of Q2 2026
$2.08M total
RENAISSANCE TECHNOLOGIES LLC
$595.4K+1495.0%
VANGUARD CAPITAL MANAGEMENT LLC
$564.8K+122.9%
CITADEL ADVISORS LLC
$206.4KNew
MAI Capital Management
$112.6K+18.6%
GEODE CAPITAL MANAGEMENT, LLC
$91.8K+3.4%
COMMONWEALTH EQUITY SERVICES, LLC
$53.5K+191.9%
HRT FINANCIAL LP
$53.0KNew
VANGUARD FIDUCIARY TRUST CO
$51.0K0.0%
BlackRock, Inc.
$45.0K0.0%
BANK OF AMERICA CORP /DE/
$42.6K-0.2%
JANE STREET GROUP, LLC
$37.9KNew
XTX Topco Ltd
$36.3K+54.7%
OSAIC HOLDINGS, INC.
$34.1K+1640.8%
US BANCORP \DE\
$31.1K0.0%
STATE STREET CORP
$28.4K0.0%
NORTHERN TRUST CORP
$21.9K+11.3%
RAYMOND JAMES FINANCIAL INC
$16.7KNew
Virtu Financial LLC
$12.0KNew
HighTower Advisors, LLC
$10.4K0.0%
FINANCIAL CONSULATE, INC
$10.4KNew
CHILTON CAPITAL MANAGEMENT LLC
$9.5K+75.7%
UBS Group AG
$8.3K-51.8%
Steward Partners Investment Advisory, LLC
$7130.0%
Vanguard Global Advisers, LLC
$5570.0%
Hilton Head Capital Partners, LLC
$4680.0%
See all 41 institutional holders →
Reading the latest SEC filing…

Key Metrics

Net Income

Q3 2026
EDGAR

EPS (Diluted)

Q3 2026
EDGAR

Free Cash Flow

Q3 2026
EDGAR

Financial Trends

Revenue & Net Income

13fpro.ai/company/CVM

Earnings Per Share

13fpro.ai/company/CVM

Loading ratio trend…

CVM key financials by period

Reported revenue, net income and operating margin by fiscal year, from CEL SCI CORP's annual filings on SEC EDGAR.

CEL SCI CORP reported revenue, net income and margins by fiscal period, from SEC filings.
PeriodRevenueNet incomeOp. margin
FY 2014$264.0K$-27.4M—
FY 2013$159.6K$-9.2M—
FY 2012$254.6K$-15.5M—
FY 2011$956.2K$-25.7M—
Source: CVM filings on SEC EDGAR →

CVM insiders

Officers, directors and 10% owners with a Form 4 filed in the last 24 months, most recent first. From SEC EDGAR.

About CEL SCI CORP (CVM): stock profile, AI score and financials

CEL SCI CORP (CVM) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. CVM is not currently included in 13F Pro's AI-ranked quality universe — below the main board's size threshold of $25m annual revenue or $100m total assets. this company reported $1.0m in revenue and is scored on the micro-cap board instead. Based on the latest XBRL financial filings (Q3 2026), CEL SCI CORP reports net income of $-5.7M, free cash flow of $-4.0M. Top institutional holders of CVM by reported 13-F value include RENAISSANCE TECHNOLOGIES, VANGUARD CAPITAL MANAGEMENT, CITADEL ADVISORS, based on the most recent SEC filings. CVM trades on the NYSE exchange and files with the SEC under CIK 725363. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate CVM daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for CEL SCI CORP directly from SEC EDGAR.

Financials through the period ended SEC EDGAR: CIK 725363 →